SEC Form 4 · accession 0001415889-15-002452
Cocrystal Pharma, Inc. · COCP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Walt Addison Linscott
Officer — GENERAL COUNSEL AND SECRETARY
Period of report
Jul 21, 2015
Accepted (ET)
Jul 23, 2015 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001412486
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock options (right to buy)F2,F1 | $0.98 | Jul 21, 2015 | A | 1,200,000 | A | — | Jul 21, 2025 | Common Stock | 1,200,000 | 1,200,000 | D |
Explanation of responses
- F1The Securities vest in four equal annual increments with the first vesting date being one year from the Transaction Date, subject to continued employment and accelerated vesting under certain conditions.
- F2Not applicable